Streptococcus pneumoniae-based immunotherapy (University of Newcastle)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameStreptococcus pneumoniae-based immunotherapy (University of Newcastle)
Drug Alias Nameimmunotherapy (University of Newcastle)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNewcastle University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAustralian Research NetworkNewcastle University
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A